MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL)

CUSIP: 558868105

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
22,766,960
Total 13F shares
17,386,191
Share change
+2,622,275
Total reported value
$2,539,343,386
Put/Call ratio
37%
Price per share
$146.04
Number of holders
206
Value change
+$349,378,221
Number of buys
123
Number of sells
91

Quarterly Holders Quick Answers

What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q3 2023

As of 30 Sep 2023, MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by 206 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,386,191 shares. The largest 10 holders included JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., STATE STREET CORP, PAULSON & CO. INC., FMR LLC, MARSHALL WACE, LLP, and ALLIANCEBERNSTEIN L.P.. This page lists 206 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.